| Annas GJ
Globalized clinical trials and informed consent. [Journal Article]
N Engl J Med 2009 May 14; 360(20):2050-3.
Full Citation | Find Related Articles |
| Loewenberg S
Drug company trials come under increasing scrutiny. [News]
Lancet 2008 Jan 19; 371(9608):191-2.
Full Citation | Find Related Articles |
| Aagaard L, Soendergaard B, Stenver DI, et al.
Knowledge creation about ADRs--turning the perspective from the rear mirror to the projector? [Journal Article]
Br J Clin Pharmacol 2008 Mar; 65(3):364-76.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Willyard C
Pfizer lawsuit spotlights ethics of developing world clinical trials. [News]
Nat Med 2007 Jul; 13(7):763.
Full Citation | Publisher Full Text | Find Related Articles |
| Lenzer J
Secret report surfaces showing that Pfizer was at fault in Nigerian drug tests. [Legal Cases, News]
BMJ 2006 May 27; 332(7552):1233.
Full Citation | Find Related Articles |
| Starr JA, Ragucci KR
Thrombocytopenia associated with intravenous ciprofloxacin. [Case Reports, Journal Article]
Pharmacotherapy 2005 Jul; 25(7):1030-4.
Abstract | Full Citation | Find Related Articles |
| Hall IH, Schwab UE, Ward ES, et al.
Effects of alatrofloxacin, the parental prodrug of trovafloxacin, on phagocytic, anti-inflammatory and immunomodulation events of human THP-1 monocytes. [Journal Article]
Biomed Pharmacother 2003 Oct; 57(8):359-65.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Lode H, Grossman C, Choudhri S, et al.
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Respir Med 2003 Oct; 97(10):1134-42.
Abstract | Full Citation | Find Related Articles |
| Raufu A
Nigerians in drug trial take their case to US court. [News]
BMJ 2003 Apr 26; 326(7395):899.
Full Citation | Publisher Full Text | Find Related Articles |
| Nakamura T, Fukuda H, Morita Y, et al.
Pharmacological evaluation of garenoxacin, a novel des-F(6)-quinolone antimicrobial agent: effects on the central nervous system. [Journal Article]
J Toxicol Sci 2003 Feb; 28(1):35-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
